ARCHITECT I2000SR ANALYZER 3M74-01

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 01 report with the FDA on 2011-02-08 for ARCHITECT I2000SR ANALYZER 3M74-01 manufactured by Abbott Manufacturing, Inc..

Event Text Entries

[1962544] The customer reports that a false positive architect cmv igg assay result (22. 8 au/ml) was generated on a liver transplant recipient. Before the surgery, a new sample was taken and tested and generated a negative result (1. 3 au/ml). The initial sample was retested and generated a negative result (2. 0 au/ml). All previous samples taken from this patient were then retested and all generated negative results. The samples also generated negative results with a non- abbott methodology. No impact to patient management was reported.
Patient Sequence No: 1, Text Type: D, B5


[8962330] (b)(4). An investigation is in process. A follow-up report will be submitted when the investigation is complete.
Patient Sequence No: 1, Text Type: N, H10


[9224768] (b)(4). The purpose of this evaluation is to investigate the performance of the architect cmv-igg reagent kit 6c15- 25 (lot 92348lf00; expiration date 04 october 2011). A retained in-house file sample of the architect cmv-igg reagent kit pack (lot 92348lf00) was used for testing. Performance testing was carried out using an in-house sample of architect cmv igg reagent (list 6c15-25, lot 92348lf00). The architect cmv igg torch negative panel was used to assess the acceptance criteria (the panel is serum based and thus mimics patient samples). An architect cmv igg assay calibration was successfully generated and control material passed, thus validating the calibration curve. Ten replicates of the architect cmv igg torch negative panel were assessed on an architect analyzer against the suspect reagent lot. The reagent lot returned results which met the specified limits, demonstrating that the reagent is meeting performance claims. The data forwarded by the customer was also reviewed. The cause of the specific discrepant patient result specified in the customer complaint was not able to be determined. It should also be noted that the control results reported by the customer met package insert specifications indicating that the reagent is performing acceptably. A review was also carried out of the testing performed by the quality control laboratory prior to approving the architect cmv igg reagent 6c15-25, lot 92348lf00 for sale. All kit release specifications were met, and no issues were identified. Review of the device history records did not identify any issues related to the customer complaint that indicate that there is a product deficiency. A review of complaint tracking and trending metrics was performed and identified no adverse trends in conjunction with the complaint issue currently under evaluation. The architect cmv igg reagent package insert and the architect i2000sr system operations manual both contain information to address the customer's current issue. Based on the results of the current investigation, it was determined that the architect cmv igg reagent, list number 6c15-25, lot number 92348lf00, identified in the complaint is performing acceptably. No malfunction of the product was determined and no additional issues were identified during the investigation of this complaint. Review of complaint tracking and trending; field service intervention.
Patient Sequence No: 1, Text Type: N, H10


[17602480] (b)(4). The evaluation began with a review of the architect i2000sr analyzer's event logs, which did not reveal any questionable data. An abbott field service engineer (fse) was on site for planned/preventive maintenance and considered the instrument to be in perfect condition; however, three parts were replaced proactively on the analyzer in conjunction with the scheduled planned/preventive maintenance. No further instrument service calls have been initiated for this analyzer since the initial call. A review of complaint tracking and trending metrics was performed and identified no adverse trends in conjunction with the complaint issue currently under evaluation. The architect system cmv igg assay package insert (ln: 6c15 (p/n 48-3349/r4, december 2008)) and the architect system operations manual (p/n 201837-108, january 2010) both contain information to address the customer's current issue. Results of the current evaluation failed to identify a single definitive cause for the customer's issue. Review of complaint tracking and trending; field service intervention.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1628664-2011-00062
MDR Report Key1981715
Report Source01
Date Received2011-02-08
Date of Report2010-01-28
Date of Event2011-01-11
Date Mfgr Received2011-03-25
Device Manufacturer Date2007-06-04
Date Added to Maude2012-01-13
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactNOEMI KONDOS RN, BSN
Manufacturer Street100 ABBOTT PARK ROAD DEPT. 09B9, LCCP1-3
Manufacturer CityABBOTT PARK IL 600643537
Manufacturer CountryUS
Manufacturer Postal600643537
Manufacturer Phone8479375120
Manufacturer G1ABBOTT MANUFACTURING, INC.
Manufacturer Street1921 HURD DRIVE
Manufacturer CityIRVING TX 75038
Manufacturer CountryUS
Manufacturer Postal Code75038
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameARCHITECT I2000SR ANALYZER
Generic NameAUTOMATED IMMUNOASSAY ANALYZER
Product CodeOMI
Date Received2011-02-08
Catalog Number3M74-01
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerABBOTT MANUFACTURING, INC.
Manufacturer Address1921 HURD DRIVE IRVING TX 75038 US 75038


Patients

Patient NumberTreatmentOutcomeDate
10 2011-02-08

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.